This study examines the distribution of A, B, and H substances in 15 syringomas and 11 control axillary skins. Monoclonal antibodies (MCABs) against A, B, and H substances with the avidin-biotin-peroxidase complex (ABC) method were used. Additionally, the H antigen was localized with Ulex europaeus Agglutinin-I (UEA-I) by use of the peroxidase-antiperoxidase method. The MCABs provided specific and reproducible staining of all 15 syringomas as well as the secretory coil and duct of normal eccrine glands. Contrariwise, apocrine and sebaceous glands were uniformly nonreactive. The staining by the UEA-I technique showed a similar pattern to that of the anti-H MCAB but with increased background (nonspecific) staining. These results, using state-of-the-art immunohistochemistry, confirm the eccrine origin of syringoma. Blood group substances may be useful in distinguishing other tumors of eccrine origin from those of apocrine origin.
sweat glands, as determined by the red blood cell adherence (RCA) test. 3 With the advent of monoclonal antibodies came precise immunologic probes readily available to the pathologist. Because these tools can aid in classifying neoplasms as well as elucidating their histogenesis, we thought it important to further evaluate the immunoantigenicity of adnexal tumors, specifically syringoma, and normal sweat glands. Using monoclonal antibodies with the avidin-biotin-peroxidase complex (ABC) technique and a lectin with the peroxidase-antiperoxidase (PAP) procedure, we found syringomas to be consistently immunoreactive for blood group substances, as are the eccrine glands but not other sweat glands.
Materials and Methods
Formalin-fixed paraffin-embedded skin was available in 15 cases of syringoma and 11 cases of normal axillary tissue removed at autopsy. Serial 5-/xm-thick sections of tumor were stained with hematoxylin and eosin, and other replicate sections were subjected to immunoperoxidase. Briefly, deparafnnized sections of tumor were treated with 0.3% (v/v) hydrogen peroxide in methanol for 30 minutes to block endogenous peroxide activity. The sections were then rehydrated and digested with 0.1% (w/v) trypsin in 0.1% (w/v) calcium chloride (0.1 g of trypsin and 0.1 g of calcium chloride diluted to 100 mL with distilled water in a 100-mL volumetric flask) brought to pH 7.8 with 0.1 mol/L sodium hydroxide, then incubated at 37 °C for 5 minutes. In all cases, sections were evaluated by use of the avidin-biotin-peroxidase complex (ABC) technique. 7 Murine monoclonal primary antibodies to blood group substances A, B, and H (1:50, Dako, Santa Barbara, CA) were applied and the sections incubated for 18 hours at -4 °C. After rinsing in 0.05 mol/L working (100 mL stock trisma [Sigma] to 900 mL of distilled water plus 8.8 g sodium 779 chloride) TRIS-buffered saline (TBS) at pH 7.6, a biotin-labeled horse antimouse IgG was added for 20 minutes, followed by the ABC technique (Stravinger® Biotin Strept Avidin ImmunoStaining Kit, Biogenex Laboratories, Dublin, CA) for 20 minutes at room temperature.
Sites of peroxidase activity were visualized with 0.025% diaminobenzidine with 0.009% (u/v) hydrogen peroxide in 0.05 mmol/L TRIS buffer (formula as above, but without sodium chloride), pH 7.6. The sections were counterstained with Harris' hematoxylin and coverslipped.
In addition, 11 of the 15 syringoma cases and all the axillary skin excisions were evaluated with Ulex europaeus Agglutinin-I (UEA-I) by the unlabeled antibody PAP method of Sternberger. 15 Incubation of the sections with 10% (v/v) normal sheep serum for 10 minutes was followed by sequential application of UEA-I, diluted 1:100, for two hours at room temperature and a polyclonal goat anti-UEA-I (1:100, Vector Laboratories, Burlington, CA) primary antibody for 18 hours at -4 °C. After rinsing with TBS, a sheep antigoat antibody (1:20, Cappel Laboratories, Cochranville, PA) was applied for 30 minutes. The final immunoreactant was goat PAP (1:200, Dako, Santa Barbara, CA).
The specificity of the immunostaining was verified by use of a positive control (pancreas) and by replacing the primary antisera with nonimmune serum of comparable dilution from the same species from which the primary antibody was produced. In addition, the ubiquity of blood-filled vessels and intimal lining of small blood vessels in the dermis and subcutaneous fat, along with the inner root sheath of the hair follicles and immunopositive stratum corneum, served as built-in positive controls. The basal layer, dermis, and subcutaneous fat were nonreactive and served as internal negative controls. Usually at least two serial sections were on each slide, thereby duplicating the immunoreaction. The epidermis and adnexa were evaluated for immunoreactivity and graded as negative, mild (scattered positive cells), moderate (most cells weakly positive), or marked (most cells strongly positive).
Results

Histologic Findings
The diagnosis of syringoma was based on well-established histologic criteria, including numerous small ducts embedded in a fibrous stroma, the walls of which were lined by two rows of epithelial cells." The latter were flat or vacuolated. The lumina of the ducts contained amorphous or keratinous debris, and some of the ducts possessed small comma-like tails of epithelial cells. Strands of neoplastic basophilic epithelial cells independent of the ducts were also seen ( Figs. 1 and 2 ). The acrosyringium, duct, and secretory coil of the eccrine glands as well as apocrine glands were readily identified in adjacent nontumorous tissue and in the axillary control tissues.
Immunohistochemistry
All syringomas demonstrated reactivity for the blood group substances and UEA-I (Fig. 2) . The immunoreactivity varied from tumor to tumor as well as from field to field within a single tumor, depending on the monoclonal antibody applied. In general, immunoreactivity was stronger with anti-B than with the other antibodies. However, most tumor cells, regardless of type of antibody, stained strongly along their cell membranes, most notably at the luminal surfaces, whereas cytoplasmic staining was mild to negative. Thirteen of the 15 tumors had intraluminal secretions; the secretions were more immunoreactive than the individual tumor cells in all 13 cases (Fig. 2) . Although our numbers are small, the distribution of blood groups in the tumors did not differ markedly from that in the general population: seven, six, and two cases were blood groups O, A, and B, respectively. All seven syringomas of blood group O expressed the H substance but lacked the A and B substances by monoclonal antibodies. UEA-I staining was performed on six of the seven cases and the reaction was comparable to the monoclonal antibody for the H substance, although less intense. Also, the UEA-I had mild nonspecific "background" staining of connective tissues not present with the monoclonal antibodies.
All syringomas that expressed the blood group A or B substances coexpressed H as well as lectin reactivity. Again, the latter immunoreactivity was mild (scattered positive cells).
Finally, in addition to tumor positivity, we noted that the eccrine sweat apparatus in all 11 control cases marked consistently for blood group substances (Fig. 2,  inset) . The degree of positivity varied within the apparatus from moderate (most cells weakly positive) in the secretory coil to marked (most cells strongly positive) in the eccrine duct. The acrosyringium also had positive results but with a weaker reaction than that seen in the underlying intradermal duct. As observed in the syringomas, immunoreactivity was maximal with anti-B and less intense with the other immunoreactants. Although the eccrine sweat gland adnexa consistently stained for blood group substances, apocrine and sebaceous glands uniformly had negative results (Fig. 3) .
Discussion
The study of the immunobiology of skin is unraveling at a feverish pa ce. 2 stances are present in skin is not known. These glycoproteins can readily be detected with a variety of immunologic methods. Using the RCA method, workers reported the selective distribution of blood group substances in eccrine but not apocrine or sebaceous glands. 3 Additionally, these immunomarkers were found in four syringomas, and it was therefore suggested that this tumor was of eccrine origin. With the advent of monoclonal antibodies the RCA has been replaced by simplified immunoenzymatic procedures. These new immunohistochemical methods provide better sensitivity and allow for a greater array of antigens to be evaluated. Monoclonal antibodies, when coupled with the ABC technique, are highly specific and provide a welldefined, semiquantitative, localized staining and permanent record of the immunoreaction. membranes (especially near the luminal surfaces), coexpression of H along with A or B substances, and variability of the staining pattern within both tumors and normal adnexal glands can be explained by the intracytoplasmic synthesis of the precursor H antigen glycoprotein and addition of carbohydrate moieties to produce A and B antigens that eventually become incorporated into the surface cell membrane. Furthermore, expression of the A, B, and H substances on skin appears to be independent of the secretory status of the patient. However, staining intensity is a measure of antigen density, which is dependent on genetic considerations such as heterogeneity of antigen (A/H, B/H) or expression of weak subgroups of blood type A or B (A 2 , A 3 , A 2 B). 14, 20 Finally, expression of substances is affected by fixation and processing of tissue, which has greater impact on those surface antigens of low density. 12 ' 8 In addition to the syringoma, we found that the eccrine sweat apparatus was also immunoreactive, in keeping with the experience of others. 3 ' 21718 However, the absence of immunoreactivity in sebaceous and apocrine glands was notable. This was a consistent and reproducible finding in all of our axillary skin controls (Fig. 3) . Recently, Penneys commented that the blood group substances A, B, and H can be demonstrated immunohistochemically within eccrine and apocrine gland epithelium. 12 Yet in his review of the immunohistochemistry of adnexal neoplasms, he offers no data or microphotographs demonstrating apocrine reactivity. In our experience, eccrine glands are immunoreactive, whereas other sweat glands completely lack blood group substances or the substances are of insufficient quantity to be readily detected by the ABC technique.
As diagnosticians, can we capitalize on the immunospecificity of sweat glands? Because most benign neoplasms probably maintain immunologic fidelity to their cell of origin, syringomas have kinship to the eccrine sweat gland because both express blood group substances. The tumor already has been established as an eccrine-derived neoplasm both histochemically and ultrastructurally. 5, 6, 8 ' 21 We now add a third modality, immunocytochemistry, which provides additional evidence that syringomas are differentiated eccrine neoplasms. Monoclonal antibodies, not only to blood group substances but to a variety of epitopes expressed in the adnexa, may ultimately "firm up" the diagnostic quagmire surrounding adnexal tumors of the skin.
